(Q44013893)

28 November 2017

Twice-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma (English)

1 reference

28 November 2017

Louis Mendelson

1

1 reference

28 November 2017

David Cook

2

1 reference

28 November 2017

Mario Cruz-Rivera

3

1 reference

28 November 2017

Sherahe Fitzpatrick

4

1 reference

28 November 2017

Joseph A Smith

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

39

1 reference

28 November 2017

227-237

1 reference

28 November 2017

3

1 reference

Chronic asthma: an update

28 November 2017

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Changes in asthma prevalence: two surveys 15 years apart

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Clinical need for a nebulized corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Epidemiology of respiratory infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycate on bronchial hyperreactivity in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Dose titration of nebulized budesonide in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Recurrent respiratory tract infections in paediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120002472

21 January 2018

Identifiers

DOI

10.1081/JAS-120002472

1 reference

28 November 2017

1 reference